Toronto, Canada

Angelica M Bello

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: University Health Network. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Angelica M Bello. Retrieved from https://idiyas.com/inventor/angelica-m-bello

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Angelica M Bello: Innovator in Malaria Treatment

Introduction

Angelica M Bello is a prominent inventor based in Toronto, Canada. She has made significant contributions to the field of medicine, particularly in the treatment of malaria. Her innovative work focuses on developing effective therapeutic methods to combat this life-threatening disease.

Latest Patents

Angelica holds 1 patent for her invention titled "ODCase inhibitors for the treatment of malaria." This patent includes methods of treating or preventing malaria by administering an anti-malarial effective amount of 6-substituted uridine derivatives to a subject in need thereof. The invention also introduces new 6-substituted uridine derivatives for use as therapeutics, specifically aimed at treating malaria.

Career Highlights

Angelica is affiliated with the University Health Network, where she continues her research and development efforts. Her work is crucial in the ongoing battle against malaria, a disease that affects millions worldwide.

Collaborations

She has collaborated with notable colleagues, including Lakshmi P Korta and Emil F Pai, to advance her research and enhance the impact of her inventions.

Conclusion

Angelica M Bello's innovative contributions to malaria treatment exemplify the vital role of inventors in addressing global health challenges. Her dedication to developing effective therapies is commendable and highlights the importance of continued research in this field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…